Pulmonary Hypertension (PH) Completed Phase 2 Trials for Ambrisentan (DB06403)

Also known as: Hypertension, Pulmonary / Pulmonary; Hypertension / Pulmonary hypertension / Hypertension Pulmonary / Pulmonary hypertensions / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00540436Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial HypertensionTreatment
NCT00046319Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial HypertensionTreatment
NCT00423592Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial HypertensionTreatment
NCT00424021Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial HypertensionTreatment